Reviva Pharmaceuticals I...
(RVPH)
undefined
undefined%
At close: undefined
2.69
2.48%
After-hours Dec 13, 2024, 07:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Net Income | -39.26M | -24.34M | -8.52M | -3.78M | -846.83K | -1.68M |
Depreciation & Amortization | - | - | - | 591.00 | 645.00 | 17.72K |
Stock-Based Compensation | 3.41M | 176.74K | 106.71K | - | - | 21.05K |
Other Working Capital | 6.96M | 2.00M | -203.71K | -3.10M | 475.98K | 541.98K |
Other Non-Cash Items | 239.22K | 194.71K | -1.55M | 2.39M | -6.41K | 28.24K |
Deferred Income Tax | - | - | - | - | - | - |
Change in Working Capital | 7.28M | 5.01M | -702.17K | -2.33M | 634.15K | 541.98K |
Operating Cash Flow | -28.32M | -18.96M | -10.67M | -3.73M | -218.44K | -1.07M |
Capital Expenditures | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - | - |
Other Investing Acitivies | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Debt Repayment | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - |
Other Financial Acitivies | 5.68M | 18.97K | 98.48K | 12.83M | - | 175.00K |
Financial Cash Flow | 33.17M | 7.79M | 31.60M | 12.83M | 100.00K | 175.00K |
Net Cash Flow | 4.85M | -11.17M | 20.93M | 8.76M | -118.44K | 118.64K |
Free Cash Flow | -28.32M | -18.96M | -10.67M | -3.73M | -218.44K | -1.07M |